Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer

Clinical trial NCT01693783 · COMPLETED

Trial details

NCT number: NCT01693783
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Adenocarcinoma Cervical Squamous Cell Carcinoma Human Papillomavirus Infection Recurrent Cervical Carcinoma Stage IVA Cervical Cancer AJCC v6 and v7 Stage IVB Cervical Cancer AJCC v6 and v7

Start date: 2012-12-03
Primary completion: 2021-03-18
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.